Black Diamond Therapeutics (BDTX) Shares Issued: 2020-2021

Historic Shares Issued for Black Diamond Therapeutics (BDTX) over the last 1 years, with Sep 2021 value amounting to $64,000.

  • Black Diamond Therapeutics' Shares Issued was N/A to $64,000 in Q3 2021 from the same period last year, while for Sep 2021 it was $214.6 million, marking a year-over-year change of. This contributed to the annual value of $24.5 million for FY2024, which is 65.91% down from last year.
  • According to the latest figures from Q3 2021, Black Diamond Therapeutics' Shares Issued is $64,000, which was down 65.22% from $184,000 recorded in Q2 2021.
  • In the past 5 years, Black Diamond Therapeutics' Shares Issued ranged from a high of $213.8 million in Q1 2020 and a low of $64,000 during Q3 2021.
  • Moreover, its 2-year median value for Shares Issued was $332,500 (2021), whereas its average is $53.6 million.
  • Data for Black Diamond Therapeutics' Shares Issued shows a maximum YoY slumped of 99.78% (in 2021) over the last 5 years.
  • Quarterly analysis of 2 years shows Black Diamond Therapeutics' Shares Issued stood at $213.8 million in 2020, then tumbled by 99.78% to $64,000 in 2021.
  • Its last three reported values are $64,000 in Q3 2021, $184,000 for Q2 2021, and $481,000 during Q1 2021.